Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Respir Physiol Neurobiol ; 276: 103410, 2020 05.
Article de Anglais | MEDLINE | ID: mdl-32036031

RÉSUMÉ

Rapidly-adapting pulmonary stretch receptors (RAPSRs) provide the central nervous system with information regarding the rate of lung inflation, lung compliance and the sensation of dyspnea. Other than satisfying parameters of an adaptation index to constant pressure lung inflation for identification, no mathematical model has been ascribed to the stimulus-response relationship of lung volume-pressure to RAPSR activity. Herein, linear, power, polynomial and non-linear (four parameters logistic) models are tested for the best "goodness of fit" line of RAPSR activity to step-wise lung inflation to four times tidal volume and constant pressure inflation to 10, 20, 30 and 40 cm H2O of the lungs of guinea pigs and dogs. Goodness of fit was determined by evaluating coefficient of determination (R2) and visual inspection. The best "goodness of fit" is one of a non-linear symmetrical, stimulus-response function.


Sujet(s)
Poumon/innervation , Neurofibres non-myélinisées/physiologie , Mécanorécepteurs pulmonaires/physiologie , Ventilation artificielle/méthodes , Animaux , Chiens , Dyspnée , Cochons d'Inde , Inspiration , Insufflation/méthodes , Modèles linéaires , Modèles logistiques , Compliance pulmonaire , Dynamique non linéaire , Volume courant , Nerf vague
2.
Respir Physiol Neurobiol ; 234: 26-31, 2016 12.
Article de Anglais | MEDLINE | ID: mdl-27595978

RÉSUMÉ

Therapeutic natural products and medicinal herbs has gained popularity. The anti-antigenic action of the plant alkaloid nordihydroguaiaretic acid (NDGA) was studied in ovalbumin (OA)-sensitized guinea pigs. In one series of experiments conscious, non-sedated guinea pigs were challenged with OA aerosol. Specific airway resistance (SRAW) was monitored using a two-chambered whole-body plethysmograph. OA aerosol increased SRAW above that produced by vehicle administration. Prior NDGA administration by a 1min 0.9% aerosol (w/vol) attenuated the increase in SRAW resulting from OA challenge. In the anesthetized guinea pig pretreated with indomethacin, pyrilamine and propranolol, intravenous OA injection increased intra-tracheal pressure above vehicle injection. Intravenous NDGA administration (5mg/kg) reduced the intra-tracheal pressure increases. In a third series of experiments plasma leukotriene C4 was measured by radio-immunoassay in 3 groups challenged with OA aerosol: vehicle-treated OA-sensitized, OA-sensitized receiving NDGA and vehicle treated guinea pigs. NDGA pretreatment reduced plasma LTC4 in response to OA challenge in OA sensitized guinea pigs. This study demonstrates that NDGA is an effective antigenic agent when given by aerosol or intravenous injection in either conscious or anesthetized guinea pigs, respectively. The mechanism of action of NDGA is presumed primarily be due to the blockage of 5-lipoxygenase and therefore the synthesis of leukotrienes.


Sujet(s)
Anaphylaxie/traitement médicamenteux , Inhibiteurs de la lipoxygénase/usage thérapeutique , Masoprocol/usage thérapeutique , Aérosols , Résistance des voies aériennes/effets des médicaments et des substances chimiques , Analyse de variance , Anaphylaxie/induit chimiquement , Animaux , Bronchoconstriction/effets des médicaments et des substances chimiques , Modèles animaux de maladie humaine , Calendrier d'administration des médicaments , Cochons d'Inde , Leucotriène C4/métabolisme , Mâle , Ovalbumine/toxicité , Pléthysmographie , Analyse de régression
3.
Respir Physiol Neurobiol ; 189(3): 639-45, 2013 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-23933030

RÉSUMÉ

Exposure to irritants such as tobacco smoke (TS) causes acute airway inflammation. Chronic exposure may cause airway remodeling contributing to enhanced airway resistance. We hypothesize that combining airway sensitization and inhalation of irritants enhances the number of mucous producing cells beyond either agent alone. Guinea pigs were antigen sensitized or treated with its vehicle. These two groups were further divided into daily exposure to TS or air. After 3 months airway reactivity to ovalbumin (OA) was determined, airway and blood samples were examined and lung substance P quantified. Combining sensitization and TS exposure increased airway reactivity to OA, goblet cell and submucosal gland populations. Airway eosinophilia was greatest in the OA-sensitized group exposed to air rather than with its combination with TS exposure. Lung substance P levels were similarly elevated in both OA-sensitized groups. Airway irritant exposure in which airway sensitization exists enhances the potential of mucus production, airway resistance and mucus plugging of the airways through increasing the number of goblet cells and submucosal glands.


Sujet(s)
Glandes exocrines/anatomopathologie , Cellules caliciformes/anatomopathologie , Ovalbumine/effets indésirables , Hypersensibilité respiratoire/induit chimiquement , Hypersensibilité respiratoire/anatomopathologie , Fumer/anatomopathologie , Administration par inhalation , Remodelage des voies aériennes/effets des médicaments et des substances chimiques , Résistance des voies aériennes/effets des médicaments et des substances chimiques , Hydroxyde d'aluminium/effets indésirables , Animaux , Cochons d'Inde , Leucocytes/anatomopathologie , Métaplasie/induit chimiquement , Fumer/effets indésirables , Fumer/physiopathologie , Facteurs temps
4.
Inflamm Allergy Drug Targets ; 8(5): 340-7, 2009 Dec.
Article de Anglais | MEDLINE | ID: mdl-20025580

RÉSUMÉ

Environmental tobacco smoke (ETS) exposure is a common health concern despite legislation to limit its presence, especially in public environments. ETS exposure is associated with changes in lung development and morphology, airway hyperresponsiveness and obstruction and development of asthma and its increased severity. However these effects of ETS exposure are not universally supported. Clinical data as well as studies in laboratory animals report ETS exposure may even attenuate airway hyperresponsiveness (AHR). Therefore, we lack complete understanding of ETS effects on pulmonary function as well as its mechanism of action. Disparate clinical and laboratory reports likely result from variables of ETS exposure, degrees of atopy and mechanisms of sensitization. The present review addresses the effects of ETS on AHR reported in humans and animal models. ETS role as an adjuvant to AHR as well as it contribution to development of antigenic tolerance is also reviewed. Possible neurogenic, cellular and intracellular mechanisms of ETS-induced ARH are proposed based on the existing literature. Enhanced understanding of the effects and mechanism of ETS will enhance therapy strategies in treatment of ARH and related disease such as COPD as well as enhancing public presentation of convincing evidence to avoid ETS.


Sujet(s)
Hyperréactivité bronchique/immunologie , Système nerveux central/physiologie , Exposition environnementale/effets indésirables , Pneumopathie infectieuse/immunologie , Pollution par la fumée de tabac/effets indésirables , Animaux , Système nerveux central/effets des médicaments et des substances chimiques , Humains , Muscles lisses/métabolisme , Neurofibres non-myélinisées/métabolisme
5.
J Asthma ; 44(9): 723-8, 2007 Nov.
Article de Anglais | MEDLINE | ID: mdl-17994401

RÉSUMÉ

Tobacco smoke (TS) exposure exacerbates asthma and may induce airway hyperresponsiveness in asymptomatic individuals. We hypothesized that TS exposure is an adjuvant to airway responsiveness. Ovalbumin (OA) sensitized guinea pigs were TS or air exposed. At 30 exposure days OA airway responsiveness was demonstrable in OA-treated animals exposed to either TS or air. After 130 exposure days only TS-exposed guinea pigs demonstrated OA airway responsiveness. Capsaicin airway responsiveness developed in non-sensitized and OA-sensitized guinea pigs exposed to TS. Therefore TS-exposure acts as an adjuvant to antigenic and neurogenic airway responsiveness. Combined antigen and adjuvant avoidance may attenuate or reverse airway responsiveness.


Sujet(s)
Hyperréactivité bronchique/induit chimiquement , Pollution par la fumée de tabac/effets indésirables , Adjuvants immunologiques , Animaux , Asthme/induit chimiquement , Liquide de lavage bronchoalvéolaire/cytologie , Capsaïcine , Cochons d'Inde , Ovalbumine , Répartition aléatoire
6.
J Asthma ; 44(7): 529-34, 2007 Sep.
Article de Anglais | MEDLINE | ID: mdl-17885855

RÉSUMÉ

Tobacco smoke (TS) exposure can induce airway hyperresponsiveness, especially in asthma. A feature of asthma is eosinophilia. We hypothesized that tobacco smoke exposure enhances eosinophil responsiveness in sensitized guinea pigs. Tobacco smoke-exposed, ovalbumin (OA)-sensitized guinea pigs were treated with TRFK-5 (1.0 mg/kg, intraperitoneal), an anti-interleukin (IL)-5 agent, or its vehicle. Guinea pigs were challenged with aerosols of OA, capsaicin, histamine, and methacholine. TRFK-5 attenuated airway responsiveness to OA but not to capsaicin, histamine, or methacholine. Bronchial alveolar lavage fluid analysis confirmed TRFK-5 attenuated airway eosinophilia in OA-treated guinea pigs. Therefore, airway responsiveness to OA is enhanced by eosinophils or IL-5 itself.


Sujet(s)
Anticorps monoclonaux/pharmacologie , Hyperréactivité bronchique/physiopathologie , Interleukine-5/antagonistes et inhibiteurs , Ovalbumine/pharmacologie , Pollution par la fumée de tabac/effets indésirables , Animaux , Hyperréactivité bronchique/étiologie , Hyperréactivité bronchique/immunologie , Capsaïcine/pharmacologie , Mouvement cellulaire , Modèles animaux de maladie humaine , Granulocytes éosinophiles/physiologie , Cochons d'Inde , Histamine/pharmacologie , Interleukine-5/immunologie , Mâle , Chlorure de méthacholine/pharmacologie
7.
J Appl Physiol (1985) ; 100(6): 1918-27, 2006 Jun.
Article de Anglais | MEDLINE | ID: mdl-16455813

RÉSUMÉ

Airway hyperresponsiveness is a cardinal feature of asthma. Lung C-fiber activation induces central and local defense reflexes that may contribute to airway hyperresponsiveness. Initial studies show that substance P (SP) activates C fibers even though it is produced and released by these same C fibers. SP may induce release of other endogenous mediators. Bradykinin (BK) is an endogenous mediator that activates C fibers. The hypothesis was tested that SP activates C fibers via BK release. Guinea pigs were anesthetized, and C-fiber activity (FA), pulmonary insufflation pressure (PIP), heart rate, and arterial blood pressure were monitored before and after intravenous injection of capsaicin (Cap), SP, and BK. Identical agonist challenges were repeated after infusion of an antagonist cocktail of des-Arg9-[Leu8]-BK (10(-3) M, B1 antagonist), and HOE-140 (10(-4) M, B2 antagonist). After antagonist administration, BK increased neither PIP nor FA. Increases in neither PIP nor FA were attenuated after Cap or SP challenge. In a second series of experiments, Cap and SP were injected before and after infusion of indomethacin (1 mg/kg iv) to determine whether either agent activates C fibers through release of arachidonic acid metabolites. Indomethacin administration decreased the effect of SP challenge on FA but not PIP. The effect of Cap on FA or PIP was not altered by indomethacin. In subsequent experiments, C fibers were activated by prostaglandin E2 and F2alpha. Therefore, exogenously applied SP stimulates an indomethacin-sensitive pathway leading to C-fiber activation.


Sujet(s)
Poumon/innervation , Poumon/physiologie , Neurofibres non-myélinisées/physiologie , Prostaglandines/physiologie , Substance P/physiologie , Potentiels d'action/effets des médicaments et des substances chimiques , Potentiels d'action/physiologie , Antagonistes bêta-adrénergiques/pharmacologie , Animaux , Asthme/physiopathologie , Pression sanguine/effets des médicaments et des substances chimiques , Pression sanguine/physiologie , Bradykinine/analogues et dérivés , Bradykinine/pharmacologie , Bradykinine/physiologie , Capsaïcine/pharmacologie , Inhibiteurs des cyclooxygénases/pharmacologie , Dinoprost/pharmacologie , Dinoprostone/pharmacologie , Cochons d'Inde , Rythme cardiaque/effets des médicaments et des substances chimiques , Rythme cardiaque/physiologie , Indométacine/pharmacologie , Neurofibres non-myélinisées/effets des médicaments et des substances chimiques , Hypersensibilité respiratoire/physiopathologie
8.
Life Sci ; 75(17): 2103-16, 2004 Sep 10.
Article de Anglais | MEDLINE | ID: mdl-15312754

RÉSUMÉ

Diabetic sensory neuropathy is an affliction that decreases sensory perception in a number of organ systems. Although little is known of its pulmonary effects certain diabetic patients have reduced airway reactivity to cold air and elevated cough threshold to irritant inhalation, reflexes reported to be mediated by pulmonary C-fibers. Therefore we studied the effects the selective C-fiber activator capsaicin (0.01% aerosol, 30 s) on variables of ventilation using a whole-body plethysmograph in age-matched rats treated with streptozotocin (STZ) or its vehicle at 6 and 12 weeks after treatment. Body weight increased and plasma glucose and glycosylated hemoglobin were stable in vehicle-treated rats. In STZ-treated rats body weight decreased and plasma glucose and glycosylated hemoglobin increased. Capsaicin challenge decreased tidal volume, respiratory rate and therefore minute ventilation in non-treated and vehicle-treated rats. However capsaicin challenge increased tidal volume thereby altering minute ventilation in STZ-treated rats. Specific airway resistance increased in both groups after capsaicin challenge. Changes in ventilation in response to capsaicin challenge in STZ-treated rats may involve C-fiber sensory neuropathy.


Sujet(s)
Capsaïcine/pharmacologie , Diabète expérimental/complications , Neuropathies diabétiques/physiopathologie , Ventilation pulmonaire/effets des médicaments et des substances chimiques , Analyse de variance , Animaux , Glycémie , Poids , Toux/induit chimiquement , Neuropathies diabétiques/complications , Modèles animaux de maladie humaine , Hémoglobine glyquée/métabolisme , Mâle , Neurofibres non-myélinisées/effets des médicaments et des substances chimiques , Pléthysmographie du corps entier , Rats , Rat Sprague-Dawley , Streptozocine , Volume courant/effets des médicaments et des substances chimiques , Facteurs temps
9.
Peptides ; 23(5): 919-26, 2002 May.
Article de Anglais | MEDLINE | ID: mdl-12084523

RÉSUMÉ

Bombesin-like peptides (BLPs) are associated with tobacco smoke (TS)-induced diseases. We sought to determine if acute TS exposure releases BLPs into the pulmonary circulation. Sensitized and non-sensitized guinea pigs were chronically exposed to TS or compressed air. Thereafter, the lungs were acutely challenged with TS while perfused. Perfusates were analyzed for BLPs. TS increased BLPs in non-sensitized guinea pigs. A separate study determined daily bombesin exposure increased lung cell counts but not airway hyperresponsivensess. TS exposure releases BLPs into the pulmonary circulation but can be modified by host factors and bombesin itself does not induce airway hyperresponsiveness.


Sujet(s)
Bombésine/sang , Poumon/vascularisation , Fumer/sang , Fumer/physiopathologie , Administration par inhalation , Aérosols , Résistance des voies aériennes/effets des médicaments et des substances chimiques , Animaux , Poids , Bombésine/administration et posologie , Bombésine/pharmacologie , Liquide de lavage bronchoalvéolaire , Capsaïcine/administration et posologie , Capsaïcine/pharmacologie , Numération cellulaire , Peptide libérant la gastrine/sang , Cochons d'Inde , Histamine/administration et posologie , Histamine/pharmacologie , Techniques in vitro , Poumon/cytologie , Poumon/effets des médicaments et des substances chimiques , Poumon/physiopathologie , Ovalbumine/administration et posologie , Ovalbumine/pharmacologie , Perfusion , Pléthysmographie du corps entier , Dosage radioimmunologique , Hypersensibilité respiratoire/induit chimiquement , Hypersensibilité respiratoire/physiopathologie , Sérotonine/administration et posologie , Sérotonine/pharmacologie , Trachée/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...